Retracted: Development of a 5-Gene Signature to Evaluate Lung Adenocarcinoma Prognosis Based on the Features of Cancer Stem Cells
- PMID: 38550164
- PMCID: PMC10977113
- DOI: 10.1155/2024/9867431
Retracted: Development of a 5-Gene Signature to Evaluate Lung Adenocarcinoma Prognosis Based on the Features of Cancer Stem Cells
Abstract
[This retracts the article DOI: 10.1155/2022/4404406.].
Copyright © 2024 BioMed Research International.
Retraction of
-
Development of a 5-Gene Signature to Evaluate Lung Adenocarcinoma Prognosis Based on the Features of Cancer Stem Cells.Biomed Res Int. 2022 Apr 16;2022:4404406. doi: 10.1155/2022/4404406. eCollection 2022. Biomed Res Int. 2022. Retraction in: Biomed Res Int. 2024 Mar 20;2024:9867431. doi: 10.1155/2024/9867431. PMID: 35480140 Free PMC article. Retracted.
References
Publication types
LinkOut - more resources
Full Text Sources
